SCHEMBL17064231

SCHEMBL17064231

O=C(O)c1c(CBr)nc(-c2nccs2)nc1-c1ccccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
TRPM4 Q8TD43 1/20 0.38
KDM4E B2RXH2 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CTSA P10619 1/20 0.37
CYP19A1 P11511 1/20 0.37
ADORA2A P29274 2/20 0.36
ALDH1A1 P00352 3/20 0.36
NR4A2 P43354 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
MGAM O43451 2/20 0.35
GAA P10253 2/20 0.35
SI P14410 2/20 0.35
MGAM2 Q2M2H8 2/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16236743 0.88 ADORA2A (0.39) HDAC3HDAC1HDAC6KDM4ENPC1
SCHEMBL17874036 0.86 CDC7 (0.46) KMT2AKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL16237487 0.86 HDAC3 (0.43) HDAC3HDAC1HDAC6TRPM4ADORA2A
SCHEMBL16237173 0.86 CTSA (0.41) HDAC3HDAC1HDAC6TRPM4CTSA
SCHEMBL16237675 0.82 ADORA2A (0.39) KMT2AKDM4ENPC1RAB9ACTSA
SCHEMBL17064250 0.82 HCRTR1 (0.39) KMT2ACTSAADORA2AMAPTADORA1
SCHEMBL16237698 0.82 ADORA2A (0.33) HDAC3HDAC1HDAC6CTSAADORA2A
SCHEMBL16237622 0.80 KMO (0.41) TRPM4NPC1RAB9AADORA2A
SCHEMBL16237522 0.78 HDAC3 (0.36) KMT2AHDAC3HDAC1HDAC6NPC1
SCHEMBL16237062 0.78 ECE1 (0.34) CTSAADORA2AECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3114128-A1 NOVEL 6-FUSED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2017-01-11 EP disclosed
WO-2015132276-A1 NOVEL 6-FUSED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2015-09-11 WO disclosed